GlassScriptPhysician profile
Joseph P Dangberg
NPI 1093032377
$3,616.42
in general payments reported to CMS, 2019-2025
40 companies · $435 in 2025
The $435 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $649 · 2021: $883 · 2022: $548 · 2023: $539 · 2024: $380 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,334 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,334.35 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $780.35 | 2021-2025 | Ubrelvy, Linzess, Qulipta |
| Astrazeneca Pharmaceuticals LP | $423.32 | 2019-2025 | Xigduo, Breztri |
| Amgen INC. | $283.67 | 2019-2023 | Repatha, Otezla |
| Glaxosmithkline, LLC. | $261.77 | 2019-2021 | |
| Pfizer INC. | $210.81 | 2019-2025 | |
| Novo Nordisk INC | $188.12 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $174.81 | 2020-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Otsuka America Pharmaceutical, INC. | $133.33 | 2022-2025 | Rexulti |
| Nestle Healthcare Nutrition INC. | $123.23 | 2023 | |
| Lilly USA, LLC | $103.43 | 2021-2024 | Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.15 | 2019-2023 | Spiriva Respimat |
| Daiichi Sankyo INC. | $80.41 | 2021-2024 | Injectafer |
| Amarin Pharma, INC. | $80.07 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $72.89 | 2021-2022 | |
| Abbott Laboratories | $56.67 | 2022-2024 | Freestyle Libre 3 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Dangberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.